Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xpand Biotechnology is a Netherlands-based biotechnology company specializing in the development of advanced orthobiologic products for bone regeneration. The company is best known for its proprietary MagnetOs technology, a synthetic bone graft substitute that utilizes a unique sub-micron surface topography to direct cellular response and promote bone formation without the need for added growth factors. Originally a spin-off from the University of Twente, Xpand was acquired by Bioventus in 2014 and now serves as a primary research and development hub for their bone graft portfolio. Its products are used globally in complex spinal fusion and orthopedic trauma surgeries to facilitate natural bone healing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xpand Biotechnology.